A Registry Trial of Targeted Intraoperative Radiation Therapy Following Breast-conserving Surgery

The purpose of this study is to evaluate the use of targeted intraoperative radiation therapy (IORT), where radiation is given one time during surgery. This study is being done to see if there are any differences between women who receive standard radiation after surgery versus those who have IORT. IORT is given during surgery after the tumor has been removed. The IORT device, called Intrabeam Device®, is FDA approved to be used in all parts of the body to deliver radiation. It can deliver radiation therapy accurately targeted to the area of the breast where the tumor has been removed while you are in the operating room.

Are you Eligible? (Inclusion Criteria)

• To be eligible for this trial, patients must be
• Female
• Age 45 years old or older with breast cancer
• Suitable for breast surgery and radiotherapy